N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-[(2S)-2-(methanesulfonamidomethyl)piperidin-1-yl]acetamide
C17H25F2N3O3S — CID 124828269
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-[(2S)-2-(methanesulfonamidomethyl)piperidin-1-yl]acetamide
N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-[(2S)-2-(methanesulfonamidomethyl)piperidin-1-yl]acetamide (PubChem CID 124828269) has the molecular formula C17H25F2N3O3S and a molecular weight of 389.47 g/mol. Its IUPAC name is N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-[(2S)-2-(methanesulfonamidomethyl)piperidin-1-yl]acetamide.
Molecular Properties
| Compound Name | N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-[(2S)-2-(methanesulfonamidomethyl)piperidin-1-yl]acetamide |
|---|---|
| PubChem CID | 124828269 |
| Molecular Formula | C17H25F2N3O3S |
| Molecular Weight | 389.47 g/mol |
| Exact Mass | 389.16 |
| IUPAC Name | N-[(1R)-1-(2,4-difluorophenyl)ethyl]-2-[(2S)-2-(methanesulfonamidomethyl)piperidin-1-yl]acetamide |
| SMILES | C[C@@H](NC(=O)CN1CCCC[C@H]1CNS(C)(=O)=O)c1ccc(F)cc1F |
| InChI | InChI=1S/C17H25F2N3O3S/c1-12(15-7-6-13(18)9-16(15)19)21-17(23)11-22-8-4-3-5-14(22)10-20-26(2,24)25/h6-7,9,12,14,20H,3-5,8,10-11H2,1-2H3,(H,21,23)/t12-,14+/m1/s1 |
| InChIKey | ILGCSIDOVBBDCE-OCCSQVGLSA-N |
| XLogP | 1.55 |
| TPSA | 78.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.47 |
| LogP ≤ 5 | 1.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124828269 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.